[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

First-Time Generics - September 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 OFLOXACIN TABLETS 200 MG, 300 MG, AND 400 MG TEVA PHARMACEUTICALS USA FLOXIN TABLETS 9/2/2003
2 AMIODARONE HYDROCHLORIDE INJECTION 50 MG/ML; PACKAGED IN 150 MG/3 ML, 450 MG/9 ML, AND 900 MG/18 ML SINGLE-USE VIALS SICOR PHARMACEUTICALS, INC. CORDARONE I.V. INJECTION 9/5/2003
3 GLIPIZIDE EXTENDED-RELEASE TABLETS 5 MG WATSON LABORATORIES, INC. GLUCOTROL XK EXTENDED-RELEASE TABLETS 9/8/2003
4 MIDODRINE HYDROCHLORIDE TABLETS 2.5 MG, 5 MG, AND 10 MG MYLAN PHARMACEUTICALS, INC. PROAMATINE TABLETS 9/10/2003
5 PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS, USP 100 MG/500 MG AAI PHARMA DARVOCET-N 100 TABLETS 9/10/2003
6 DOXYCYCLINE CAPSULES, USP 75 MG (ADDITIONAL STRENGTH) RANBAXY LABORATORIES LIMITED MONODOX CAPSULES 9/10/2003
7 CEPHALEXIN TABLETS FOR ORAL SUSPENSION 125 MG AND 250 MG RANBAXY LABORATORIES LIMITED KEFLEX FOR ORAL SUSPENSION 9/11/2003
8 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG PUREPAC PHARMACEUTICAL CO. NEOURONTIN CAPSULES 9/12/2003
9 HYDROCODONE BITARTRATE AND ACETAMINOPHEN ORAL SOLUTION 7.5 MG/325 MG PER 15 ML MIKART INC. LORTAB ELIXIR 9/25/2003

Back to Top     Back to Approvals

Date created: 10/9/2003

horizonal rule